Edition:
India

People: Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

62.85USD
17 Sep 2020
Change (% chg)

$-0.01 (-0.02%)
Prev Close
$62.86
Open
$61.97
Day's High
$63.31
Day's Low
$61.97
Volume
66,157
Avg. Vol
154,106
52-wk High
$78.69
52-wk Low
$26.56

Gentile, Kimberly 

Ms. Kimberly A. Gentile serves as Senior Vice President - Clinical Operations of the Company. Ms. Gentile has served as our senior vice president, clinical operations since February 2014. Before coming to Biohaven, Ms. Gentile served as associate director, project manager, global clinical operations at BMS from 2000 to February 2014. Prior to this, she was a senior clinical trial manager at SCIREX Corporation from 1996 to June 2000. Ms. Gentile received her B.S. in Psychology from Salem State University.

Basic Compensation

Total Annual Compensation, USD 1,805,760
Restricted Stock Award, USD 861,000
Long-Term Incentive Plans, USD --
All Other, USD 13,734
Fiscal Year Total, USD 2,680,490

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 27,500 960,142.00
Name Fiscal Year Total

Thomas Lynch

--

Vlad Coric

6,787,630

James Engelhart

2,560,770

Kimberly Gentile

2,680,490

Charles Conway

2,792,860

Robert Berman

521,060
As Of  31 Dec 2019